Zoetis ROA 2011-2018 | ZTS

Current and historical return on assets (ROA) values for Zoetis (ZTS) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Zoetis ROA for the three months ending September 30, 2018 was 16.49%.
Zoetis ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $1.16B $10.46B 12.81%
2018-06-30 $1.12B $8.60B 12.68%
2018-03-31 $0.98B $8.69B 11.38%
2017-12-31 $0.86B $8.59B 10.37%
2017-09-30 $0.94B $9.29B 11.57%
2017-06-30 $0.88B $7.80B 11.40%
2017-03-31 $0.86B $7.65B 11.20%
2016-12-31 $0.82B $7.65B 10.83%
2016-09-30 $0.69B $7.72B 9.01%
2016-06-30 $0.64B $7.52B 8.64%
2016-03-31 $0.38B $7.45B 5.28%
2015-12-31 $0.34B $7.91B 4.91%
2015-09-30 $0.44B $6.69B 6.74%
2015-06-30 $0.42B $6.60B 6.43%
2015-03-31 $0.59B $6.43B 9.10%
2014-12-31 $0.58B $6.59B 8.96%
2014-09-30 $0.56B $6.53B 8.64%
2014-06-30 $0.53B $6.52B 8.19%
2014-03-31 $0.52B $6.40B 8.15%
2013-12-31 $0.50B $6.56B 7.99%
2013-09-30 $0.39B $6.26B 6.24%
2013-06-30 $0.42B $6.26B 9.00%
2013-03-31 $0.47B $6.14B 15.00%
2012-12-31 $0.44B $6.26B 27.85%
2012-09-30 $0.45B $0.00B 31.24%
2012-06-30 $0.28B $0.00B 19.89%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $44.807B $5.825B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $31.419B 11.62
Grifols (GRFS) Spain $13.084B 15.86
Ionis Pharmaceuticals (IONS) United States $8.099B 0.00
Neurocrine Biosciences (NBIX) United States $7.679B 497.35
Jazz Pharmaceuticals (JAZZ) Ireland $7.560B 10.85
Sage Therapeutics (SAGE) United States $7.412B 0.00
Nektar Therapeutics (NKTR) United States $7.377B 10.58
Loxo Oncology (LOXO) United States $7.184B 0.00
Tilray (TLRY) United States $7.138B 0.00
Catalent (CTLT) United States $6.055B 25.35
United Therapeutics (UTHR) United States $5.167B 8.45
FibroGen (FGEN) United States $4.840B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.117B 13.25
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.953B 21.02
USANA Health Sciences (USNA) United States $2.562B 20.91
Endo (ENDP) Ireland $2.360B 3.62
Ironwood Pharmaceuticals (IRWD) United States $2.144B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.062B 0.00
Heron Therapeutics (HRTX) United States $2.044B 0.00
Portola Pharmaceuticals (PTLA) United States $1.980B 0.00
Zogenix (ZGNX) United States $1.975B 0.00
Xencor (XNCR) United States $1.972B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.886B 23.49
Aerie Pharmaceuticals (AERI) United States $1.867B 0.00
PTC Therapeutics (PTCT) United States $1.665B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.659B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.631B 220.44
Theravance Biopharma (TBPH) Cayman Islands $1.493B 0.00
TherapeuticsMD (TXMD) United States $1.363B 0.00
Corcept Therapeutics (CORT) United States $1.314B 19.29
Spectrum Pharmaceuticals (SPPI) United States $1.251B 0.00
Esperion Therapeutics (ESPR) United States $1.193B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.986B 0.00
Tricida (TCDA) United States $0.936B 0.00
ImmunoGen (IMGN) United States $0.819B 0.00
Radius Health (RDUS) United States $0.805B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.588B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.562B 0.00
ChemoCentryx (CCXI) United States $0.549B 43.44
Siga Technologies (SIGA) United States $0.542B 0.00
Flexion Therapeutics (FLXN) United States $0.537B 0.00
Karyopharm Therapeutics (KPTI) United States $0.535B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.495B 29.18
GlycoMimetics (GLYC) United States $0.494B 0.00
Forty Seven (FTSV) United States $0.479B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.466B 0.00
Collegium Pharmaceutical (COLL) United States $0.462B 0.00
Odonate Therapeutics (ODT) United States $0.446B 0.00
Aptorum Group (APM) China $0.429B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.378B 0.00
Akebia Therapeutics (AKBA) United States $0.369B 0.00
Lannett Co Inc (LCI) United States $0.367B 3.41
ArQule (ARQL) United States $0.351B 0.00
KalVista Pharmaceuticals (KALV) United States $0.338B 0.00
CASI Pharmaceuticals (CASI) United States $0.334B 0.00
Concert Pharmaceuticals (CNCE) United States $0.334B 0.00
Majesco Entertainment (PTE) United States $0.333B 0.00
Translate Bio (TBIO) United States $0.333B 0.00
Tyme Technologies (TYME) United States $0.323B 0.00
Dermira (DERM) United States $0.319B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.308B 0.00
Aclaris Therapeutics (ACRS) United States $0.305B 0.00
OptiNose (OPTN) United States $0.295B 0.00
Minerva Neurosciences (NERV) United States $0.282B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.279B 10.38
Catalyst Pharmaceuticals (CPRX) United States $0.278B 0.00
Mast Therapeutics (SVRA) United States $0.244B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.242B 0.00
Opexa Therapeutics (ACER) United States $0.227B 0.00
IMV INC (IMV) Canada $0.225B 0.00
Affimed (AFMD) Germany $0.217B 0.00
Dova Pharmaceuticals (DOVA) United States $0.214B 0.00
MEI Pharma (MEIP) United States $0.210B 0.00
Aratana Therapeutics (PETX) United States $0.210B 0.00
Aldeyra Therapeutics (ALDX) United States $0.209B 0.00
Rafael Holdings (RFL) United States $0.207B 0.00
ElectroCore (ECOR) United States $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
Calithera Biosciences (CALA) United States $0.199B 0.00
Xeris Pharmaceuticals (XERS) United States $0.192B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.192B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.189B 0.00
Recro Pharma (REPH) United States $0.184B 0.00
Redhill Biopharma (RDHL) Israel $0.179B 0.00
Molecular Templates (MTEM) United States $0.165B 0.00
Zafgen (ZFGN) United States $0.164B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.163B 0.00
Nature's Sunshine Products (NATR) United States $0.160B 0.00
Aquestive Therapeutics (AQST) United States $0.160B 0.00
Ardelyx (ARDX) United States $0.157B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.156B 0.00
AgeX Therapeutics (AGE) United States $0.155B 0.00
Ocular Therapeutix (OCUL) United States $0.152B 0.00
Adherex Technologies (FENC) United States $0.148B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.148B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.147B 0.00
Jounce Therapeutics (JNCE) United States $0.141B 0.00
Neon Therapeutics (NTGN) United States $0.140B 0.00
Cardiome Pharma (CORV) Canada $0.137B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.136B 0.00
MediWound (MDWD) Israel $0.127B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.119B 0.00
China SXT Pharmaceuticals (SXTC) China $0.118B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.117B 0.00
ProNAi Therapeutics (SRRA) Canada $0.115B 0.00
DURECT (DRRX) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.088B 0.00
Iterum Therapeutics (ITRM) Ireland $0.084B 0.00
Melinta Therapeutics (MLNT) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.080B 7.80
Infinity Pharmaceuticals (INFI) United States $0.077B 0.00
Nivalis Therapeutics (ALPN) United States $0.077B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.073B 0.00
Immune Design (IMDZ) United States $0.070B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
Forward Pharma (FWP) Denmark $0.068B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Achaogen (AKAO) United States $0.065B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.064B 0.00
Avenue Therapeutics (ATXI) United States $0.063B 0.00
KemPharm (KMPH) United States $0.062B 0.00
Otonomy (OTIC) United States $0.062B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.062B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.053B 0.00
Mannatechorporated (MTEX) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Genocea Biosciences (GNCA) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
Capnia (SLNO) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Lipocine (LPCN) United States $0.035B 0.00
ContraFect (CFRX) United States $0.034B 0.00
Heat Biologics (HTBX) United States $0.033B 0.00
NOVAN INC (NOVN) United States $0.032B 0.00
NanoViricides (NNVC) United States $0.029B 0.00
IsoRay (ISR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Biomerica (BMRA) United States $0.024B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
Xenetic Biosciences (XBIO) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.020B 0.00
Trillium Therapeutics (TRIL) Canada $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Onconova Therapeutics (ONTX) United States $0.018B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.016B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
VAXART, INC (VXRT) United States $0.014B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.014B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Shineco (TYHT) China $0.011B 1.15
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Intellipharmaceutics (IPCI) Canada $0.006B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00